Washington DC
Rockville-based MacroGenics reports $20.1 million loss in Q3
MacroGenics Inc. posted a $20.1 million loss and $18.7 million revenue in the third quarter, according to a report.
Photo: Ad Meskens / CC BY-SA 3.0, via Wikimedia Commons
Rockville-based biopharmaceutical company MacroGenics Inc. reported a loss of $20.1 million in its third quarter, according to an Associated Press report via WTOP.
The company stated a loss of 32 cents per share, or 34 cents per share when adjusted for discontinued operations, the report said.
MacroGenics posted revenue of $18.7 million during the quarter, according to the report.
This financial update reflects the company's recent performance and outlook, as reported by WTOP.
No further details on future projections or operational changes were provided in the report.
Sources
We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.
Comments
No comments yet.
Sign in to comment